call for cases

11
Call for CASES Leszek D. Stachaczyk, MD Pawel Buszman, MD, FESC, FSCAI American Heart of Poland, Ustroñ, Poland & CCU, Upper-Silesian Center of Cardiology, Silesian Medical School, Katowice, Poland Percutaneous closure of coronary artery aneurysm: long term implication

Upload: airell

Post on 06-Jan-2016

31 views

Category:

Documents


0 download

DESCRIPTION

Call for CASES. Percutaneous closure of coronary artery aneurysm: long term implication. Leszek D. Stachaczyk , MD Pawel Buszman, MD, FESC, FSCAI American Heart of Poland, Ustroñ, Poland & CCU, Upper-Silesian Center of Cardiology, Silesian Medical School, Katowice, Poland. Introduction. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Call for CASES

Call for CASES

Leszek D. Stachaczyk, MDPawel Buszman, MD, FESC, FSCAI

American Heart of Poland, Ustroñ, Poland&

CCU, Upper-Silesian Center of Cardiology, Silesian Medical School, Katowice, Poland

Leszek D. Stachaczyk, MDPawel Buszman, MD, FESC, FSCAI

American Heart of Poland, Ustroñ, Poland&

CCU, Upper-Silesian Center of Cardiology, Silesian Medical School, Katowice, Poland

Percutaneous closure of coronary artery aneurysm:

long term implication

Percutaneous closure of coronary artery aneurysm:

long term implication

Page 2: Call for CASES

Introduction

Atherosclerosis of coronary artery may result in lumen narrowing or anurysm formation.

Coronary anurysm enhances the risk of local thrombosis and/or peripheral embolisation.

There is no established treatment for large coronary aneurysms.

Atherosclerosis of coronary artery may result in lumen narrowing or anurysm formation.

Coronary anurysm enhances the risk of local thrombosis and/or peripheral embolisation.

There is no established treatment for large coronary aneurysms.

Page 3: Call for CASES

• Age 47 / male

• Symptoms: Unstable Angina.

• Medical History: non-Q myocardial infarction in 1994.

• Risk factors: Hypercholesterolaemia, ex-smoker.

• Age 47 / male

• Symptoms: Unstable Angina.

• Medical History: non-Q myocardial infarction in 1994.

• Risk factors: Hypercholesterolaemia, ex-smoker.

Description of the problemCase report:

Page 4: Call for CASES

Description of the problem

• Concomitant treatment of coronary artery Concomitant treatment of coronary artery stenosis and aneurysm.stenosis and aneurysm.

• Percutaneous cPercutaneous closure of left anterior losure of left anterior descending coronary artery aneurysm with descending coronary artery aneurysm with stent graft.stent graft.

• Concomitant treatment of coronary artery Concomitant treatment of coronary artery stenosis and aneurysm.stenosis and aneurysm.

• Percutaneous cPercutaneous closure of left anterior losure of left anterior descending coronary artery aneurysm with descending coronary artery aneurysm with stent graft.stent graft.

Page 5: Call for CASES

Left anterior descending coronary artery aneurysm.

Left anterior descending coronary artery aneurysm.

LCA: RAO 30

Coronary angiography:

LCA:LM-short, without narrowingLAD-proximal aneurysm (diam. ca 5-6mm), critical narrowings in med segment (90 and 75%)Cx-50-60% lesion in med segment.

RCA: dominant, normal.

Page 6: Call for CASES

Intended strategy

• Guiding catheter: Judkins Left 4, 7F

• Stent graft Jostent 3.0x16mm on balloon 3.5x20mm Quantuum

• Predilatation of LAD and placement of a PTFE – covered stent

• Direct stenting to med Cx

• Guiding catheter: Judkins Left 4, 7F

• Stent graft Jostent 3.0x16mm on balloon 3.5x20mm Quantuum

• Predilatation of LAD and placement of a PTFE – covered stent

• Direct stenting to med Cx

Technical data:Technical data:

Page 7: Call for CASES

Stenting

• Administration of ticlopidine and ASA 2 days before procedure

• Routine anticoagulation during procedure.

• Predilatation and stent implantation to LAD (3.0 / 16mm Jostent coronary stent graft with 16 atm)

• Direct stenting to med Cx

• Administration of ticlopidine and ASA 2 days before procedure

• Routine anticoagulation during procedure.

• Predilatation and stent implantation to LAD (3.0 / 16mm Jostent coronary stent graft with 16 atm)

• Direct stenting to med Cx

Page 8: Call for CASES

Acute Result

• TIMI 3 flow after stent implantation

• Non significant residual stenosis

• No complication

• TIMI 3 flow after stent implantation

• Non significant residual stenosis

• No complication

Page 9: Call for CASES

Long-term sequel

• Acute MI after 6 months (late in-stent thrombosis)

• Successful thrombolysis combined with IIb/IIIa inhibitor.

• Acute MI after 6 months (late in-stent thrombosis)

• Successful thrombolysis combined with IIb/IIIa inhibitor.

Page 10: Call for CASES

Summary

• A 47 year old male with unstable angina was addmitted to the hospital for interventional diagnosis and treatment.

• Coronary angiography showed a LAD eccentric aneurysm and double-vessel coronary artery disease (LAD, Cx).

• The aneurysm and the lesion in proximal portion of LAD were treated with stent graft. The lesion more distally was treated with balloon angioplasty. Lesion in the Cx was stented.

• Patient left hospital on combined antiplatelet therapy with aspirin and ticlopidine ordered for 3 months.

• After 6 months patient suffered from anterior AMI caused by late in-stent thrombosis, which was successfully treated with thrombolysis and IIb/IIIa inhibitor.

• A 47 year old male with unstable angina was addmitted to the hospital for interventional diagnosis and treatment.

• Coronary angiography showed a LAD eccentric aneurysm and double-vessel coronary artery disease (LAD, Cx).

• The aneurysm and the lesion in proximal portion of LAD were treated with stent graft. The lesion more distally was treated with balloon angioplasty. Lesion in the Cx was stented.

• Patient left hospital on combined antiplatelet therapy with aspirin and ticlopidine ordered for 3 months.

• After 6 months patient suffered from anterior AMI caused by late in-stent thrombosis, which was successfully treated with thrombolysis and IIb/IIIa inhibitor.

Page 11: Call for CASES

Message

• Percutaneous coronary aneurysm closure with Jostent Graft is feasible and efficient.

• The use of this stent requires an extended course of double antiplatelet therapy.

• Percutaneous coronary aneurysm closure with Jostent Graft is feasible and efficient.

• The use of this stent requires an extended course of double antiplatelet therapy.